Cutler Group LP Amylyx Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,000 shares of AMLX stock, worth $13,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 900
11.11%
Holding current value
$13,700
Previous $13,000
84.62%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
143Shares Held
75.8MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$121 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$108 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$81.4 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$62.1 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$61.6 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $802M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...